# Panacea Future Resilience OS — 2030 anti-regret architecture

Status: additive non-UI operating contract. This document defines how Panacea remains scientifically current and technically replaceable as the external technology landscape changes.

## Objective

The objective is not to predict which model, device vendor, cloud, database, renderer or framework will dominate in 2030.

The objective is to make a future technology change **a bounded migration instead of a product rewrite**.

Panacea therefore treats its durable value as:

- the longitudinal patient and health state;
- clinical governance and human review;
- evidence provenance and uncertainty;
- device/imaging normalization contracts;
- Body Exposure semantic state;
- user history and consent;
- validated workflows;
- evaluation suites;
- interoperable schemas;
- the team’s accumulated decisions and audit trail.

Vendors, models, SDKs, renderers, clouds and storage engines are replaceable implementation edges.

No architecture can guarantee that a founder will never regret a technical decision. This OS instead reduces avoidable regret by maximizing **optionality, reversibility, evidence freshness and migration readiness**.

## 1. Core rule: stable contracts, replaceable edges

A technology is never allowed to become Panacea’s identity.

Examples:

- OpenAI, Anthropic, Google, open-source or future model providers sit behind an AI runtime contract.
- Garmin, Apple, WHOOP, Oura, bedside monitors and future devices sit behind device adapters.
- Vercel, Render, AWS, GCP or a future deployment platform sit behind documented runtime/deployment assumptions.
- Three.js, WebGPU renderers or future 3D engines sit behind Body Exposure scene/semantic contracts.
- FHIR, DICOM, IHE and IEEE versions are handled through versioned interoperability adapters.
- Search/vector/database products may change without becoming the canonical source of patient truth.

**2030 rule:** no critical Panacea capability should depend on exactly one vendor or proprietary data format without a documented export path, adapter boundary and rollback route.

## 2. Continuous research loop

Panacea uses four nested review cadences.

### Weekly — repository risk review

Check:

- failing tests and CI;
- hard-coded vendor coupling;
- dependency/security advisories;
- deprecated SDK/API use;
- schema migrations without rollback;
- missing adapter tests;
- stale source fixtures;
- unresolved clinical/evidence provenance gaps;
- open PR overlap and architecture duplication.

The weekly output is a short risk queue, not a redesign.

### Monthly — horizon scan

Review material changes in:

- foundation models and agent runtimes;
- medical AI evaluation and clinical safety;
- FHIR / DICOM / IHE / IEEE 11073 interoperability;
- medical-device APIs and authorized vendor interfaces;
- WebGPU / browser / mobile rendering;
- 3D anatomy, volumetric rendering and simulation tooling;
- storage, streaming, vector/search and event infrastructure;
- privacy, identity, secrets, audit and consent tooling;
- deployment/runtime platforms;
- relevant regulation, guidance and scientific evidence.

Every candidate must record:

- exact source;
- retrieval/review date;
- what changed;
- affected Panacea capability;
- expected upside;
- compatibility;
- security and clinical-safety implications;
- migration cost;
- lock-in;
- unknowns;
- recommended experiment.

### Quarterly — replacement drill

Pick one important dependency and answer:

1. Can Panacea export its state?
2. Can another adapter reproduce the required contract?
3. Can tests run against both implementations?
4. Can the new implementation operate in shadow mode?
5. Is rollback possible without data loss?
6. Does the clinical/evidence boundary remain unchanged?

A replacement drill may end with **no migration**. The value is proving that migration remains possible.

### Annual — architectural survival review

Ask:

- Which capability would be hardest to replace today?
- Which proprietary assumption has become product-critical?
- Which evidence/standard version is stale?
- Which subsystem cannot be reconstructed from code + schema + fixtures + decisions?
- Which module has no credible second implementation path?
- Which human/team knowledge exists only in one person’s head?

The result becomes the next year’s resilience roadmap.

## 3. Quantitative heuristics

These are engineering prioritization formulas, not clinical probabilities or predictions of company survival.

All dimensions are normalized to [0,1].

### Resilience Index

```text
ResilienceIndex =
  0.16 * contractCoverage
+ 0.14 * automatedTestCoverage
+ 0.15 * providerAbstraction
+ 0.15 * dataPortability
+ 0.10 * observability
+ 0.12 * rollbackReadiness
+ 0.10 * evidenceFreshness
+ 0.08 * teamContinuity
```

Interpretation:

- < 0.50: fragile
- 0.50–0.69: exposed
- 0.70–0.84: resilient
- >= 0.85: anti-fragile target state

This index is implemented in `src/lib/futureResilienceOS.ts`.

### Adoption Readiness

```text
AdoptionReadiness =
  0.18 * maturity
+ 0.16 * compatibility
+ 0.14 * portability
+ 0.12 * reversibility
+ 0.15 * security
+ 0.15 * clinicalSafety
+ 0.05 * (1 - migrationCost)
+ 0.05 * (1 - vendorLockIn)
```

A new technology cannot replace a critical implementation merely because it is impressive.

Replacement requires:

- AdoptionReadiness >= 0.80;
- security >= 0.70;
- clinicalSafety >= 0.70;
- canonical-contract compatibility >= 0.60;
- portability >= 0.50;
- validated benchmark **with an auditable evidence reference**;
- validated shadow mode **with an auditable evidence reference**;
- validated rollback **with an auditable evidence reference**;
- a non-empty authoritative source reference and parseable assessment date.

A boolean such as `benchmarkValidated: true` is not sufficient evidence by itself. The runtime gate fails closed when the benchmark, shadow, or rollback claim lacks a durable artifact/reference pointer.

### Obsolescence Pressure

```text
ObsolescencePressure =
  0.40 * vendorLockIn
+ 0.30 * migrationCost
+ 0.20 * (1 - portability)
+ 0.10 * (1 - reversibility)
```

High pressure means **research escape routes earlier**. It does not mean “replace now.”

### Evidence Freshness Pressure

```text
FreshnessPressure = min(1, evidenceAgeDays / 180)
```

For fast-moving technology domains, six months without reassessment reaches maximum freshness pressure.

### Research Urgency

```text
ResearchUrgency =
  0.50 * expectedUpside
+ 0.30 * ObsolescencePressure
+ 0.20 * FreshnessPressure
```

Research urgency and adoption readiness are deliberately separate.

A technology may be urgent to investigate but unsafe to adopt.

## 4. Migration protocol

Every important technology replacement follows the same sequence.

```text
detect change
→ verify authoritative source
→ reproduce current baseline
→ implement adapter
→ run deterministic tests
→ benchmark old vs new
→ run shadow mode
→ inspect safety/provenance/data parity
→ canary/staged rollout
→ cut over
→ retain rollback window
→ deprecate old adapter only after evidence
```

For clinical or health-critical behavior, no migration may silently weaken:

- patient identity integrity;
- provenance;
- consent;
- auditability;
- clinician review;
- uncertainty display;
- high-risk safety gates;
- FHIR/DICOM/device semantics;
- data export or recovery.

## 5. Research source hierarchy

Prefer evidence in this order when deciding whether a technology materially changes Panacea:

1. official standards bodies, regulators and vendor documentation;
2. peer-reviewed literature and validated benchmarks;
3. reproducible open-source implementation evidence;
4. independent engineering reports;
5. community reports as hypothesis-generating signals only.

Marketing claims are not validation.

For every reviewed technology, store the **source, version/date, retrieval date, test fixture and limitations**. Any candidate eligible for cutover must additionally retain durable references for the benchmark result, shadow-run evidence, and rollback proof; undocumented "validated" flags fail closed.

## 6. Panacea capability surfaces

The canonical runtime registry in `src/lib/futureResilienceOS.ts` covers:

- AI runtime;
- evidence retrieval;
- clinical data;
- medical-device ingestion;
- imaging;
- Body Exposure rendering;
- identity/auth;
- storage;
- interoperability;
- deployment;
- security/privacy.

The list should grow only when a genuinely new architectural surface exists. Do not create a separate architecture for every new vendor.

## 7. What should never be “future-proofed” by freezing it

Do not preserve an old technology merely because migration is uncomfortable.

Equally, do not replace a working technology merely because a newer one is fashionable.

The durable object is the **contract and evidence**, not the implementation.

Examples:

- If a future model is dramatically stronger, swap the adapter after benchmark/shadow/rollback gates.
- If WebGPU or a future renderer materially improves Body Exposure, preserve semantic structure identity, selection, provenance and multiscale state while replacing the rendering engine.
- If a future wearable or hospital device appears, normalize it through the Medical Device Fabric rather than creating a parallel health state.
- If a new interoperability version supersedes an older one, version the mapping and migrate without changing clinical meaning.
- If a storage engine becomes unsuitable, export, migrate and replay validation before cutover.

## 8. Team continuity is part of technical resilience

A product can become obsolete even with modern code if only one person understands it.

Every long-running subsystem should have:

- a canonical contract;
- decision notes;
- fixtures;
- tests;
- provenance;
- migration notes;
- operational failure modes;
- a continuation/handoff path.

The goal is that ChatGPT, Claude Code, a human engineer or a future agent can reconstruct **why** the system behaves as it does.

## 9. Integration with current Panacea architecture

This OS must build on, not replace:

- the canonical longitudinal patient state;
- AI-EMR as the clinical source of truth;
- Visit OS;
- Medical Device Fabric;
- DICOM/imaging infrastructure;
- Body Exposure shared semantic state;
- Academic Accuracy Gate;
- clinical-publication/human-review boundaries;
- existing multi-agent coordination rules.

The currently open Translational Acceleration OS is complementary: it accelerates discovery/translational workflows. Future Resilience OS protects the broader Panacea platform from technical and architectural obsolescence.

## 10. Immediate implementation order

1. Land the resilience kernel and QA tests.
2. Add the QA test to the default build gate.
3. Create a scheduled repository radar that checks deterministic technical drift without auto-migrating critical infrastructure.
4. Add real provider/adapter conformance matrices for AI, devices, interoperability and deployment.
5. Add benchmark fixtures so model/renderer/storage replacements can be compared against stable product outcomes.
6. Add quarterly portability drills and record results.
7. Keep the horizon scan evidence-driven and small; novelty does not equal progress.

## References

1. ISO 14971:2019. Medical devices — Application of risk management to medical devices.
2. IEC 62304:2006 + AMD1:2015. Medical device software — Software life cycle processes.
3. NIST. Artificial Intelligence Risk Management Framework (AI RMF 1.0), 2023.
4. NIST AI 600-1. Artificial Intelligence Risk Management Framework: Generative Artificial Intelligence Profile, 2024.
5. HL7. FHIR specification family. Use the version required by the target integration and preserve explicit versioned mappings.
6. DICOM Standards Committee. Digital Imaging and Communications in Medicine (DICOM) Standard.
7. IHE International. Devices Technical Framework.
8. IEEE 11073 family. Health informatics / medical-device communication standards.
9. W3C. WebGPU specification. Treat renderer support as a replaceable capability behind Body Exposure semantic contracts.
10. Fowler M. Strangler Fig Application pattern. Use incremental replacement at stable seams rather than high-risk whole-system rewrites.

Reference versions must be rechecked during each horizon review; listing a standard here is not evidence that a specific implementation remains current or conformant.
